Related Experiment Video

Updated: Jul 9, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Biochemical markers for the prediction of preterm delivery

John D Yeast1, George Lu

  • 1Department of Obstetrics and Gynecology, University of Missouri-Kansas City, 2301 Holmes, Kansas City, MO 64108, USA. jyeast@saint-lukes.org

Clinics in Perinatology
|December 8, 2007
PubMed

Insights

Spontaneous preterm birth remains a significant global health challenge, contributing to infant illness and death. Despite medical advancements, its frequency has not decreased over the last fifty years.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Perinatal Medicine
  • Public Health

Background:

  • Preterm delivery is a leading cause of infant mortality and morbidity worldwide.
  • In the U.S., approximately 1 in 8 infants are born prematurely.
  • While some preterm births are medically indicated, spontaneous preterm births remain a persistent issue.

Purpose of the Study:

  • To highlight the ongoing impact of preterm delivery on perinatal health outcomes.
  • To underscore the stagnation in spontaneous preterm birth rates over the past five decades.

Main Methods:

  • Analysis of global and national statistics on preterm birth rates.
  • Review of trends in indicated versus spontaneous preterm deliveries.
  • Examination of historical data spanning the last 50 years.

Main Results:

  • Preterm delivery is identified as the primary factor in perinatal morbidity and mortality globally.
  • The rate of spontaneous preterm birth in the United States has shown no significant change over the last 50 years.

Conclusions:

  • Spontaneous preterm birth represents a critical, unresolved challenge in perinatal medicine.
  • Further research and interventions are needed to address the persistent rates of preterm birth.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...